BR0108757A - Peptìdeos memno processo para a preparação dos mesmos e uso dos mesmos - Google Patents
Peptìdeos memno processo para a preparação dos mesmos e uso dos mesmosInfo
- Publication number
- BR0108757A BR0108757A BR0108757-6A BR0108757A BR0108757A BR 0108757 A BR0108757 A BR 0108757A BR 0108757 A BR0108757 A BR 0108757A BR 0108757 A BR0108757 A BR 0108757A
- Authority
- BR
- Brazil
- Prior art keywords
- peptides
- preparation
- same
- preparing
- dsm
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 241001598067 Memnoniella echinata Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229940127557 pharmaceutical product Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Cardiology (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
"PEPTìDEOS MEMNO PROCESSO PARA A PREPARAçãO DOS MESMOS E USO DOS MESMOS". A invenção refere-se a derivados de peptídeo, chamados peptídeos memno, de fórmula (I): em que R~ 1~, R~ 2~, R~ 3~, R~ 4~, R~ 5~, R~ 6~, R~ 7~, R~ 8~ e (A)n têm o significado aqui, que podem ser obtidos por cultivo de Memnoniella echinata FH 2272, DSM 13195 ou de mutantes e de variantes deste, a um processo para a preparação dos mesmos e ao uso dos compostos como produtos farmacêuticos, por exemplo, contra a insuficiência cardíaca.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00104114A EP1130027A1 (de) | 2000-02-29 | 2000-02-29 | Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben |
| PCT/EP2001/001661 WO2001064715A2 (en) | 2000-02-29 | 2001-02-15 | Memno peptides, a process for their preparation and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0108757A true BR0108757A (pt) | 2002-12-10 |
Family
ID=8167973
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0108757-6A BR0108757A (pt) | 2000-02-29 | 2001-02-15 | Peptìdeos memno processo para a preparação dos mesmos e uso dos mesmos |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6627604B2 (pt) |
| EP (2) | EP1130027A1 (pt) |
| JP (1) | JP4787449B2 (pt) |
| KR (1) | KR100997073B1 (pt) |
| CN (1) | CN1274715C (pt) |
| AR (1) | AR029808A1 (pt) |
| AT (1) | ATE313556T1 (pt) |
| AU (2) | AU2001250318B2 (pt) |
| BR (1) | BR0108757A (pt) |
| CA (1) | CA2401032C (pt) |
| CY (1) | CY1105550T1 (pt) |
| CZ (1) | CZ303552B6 (pt) |
| DE (1) | DE60116063T2 (pt) |
| DK (1) | DK1261625T3 (pt) |
| EE (1) | EE05406B1 (pt) |
| ES (1) | ES2254394T3 (pt) |
| HK (1) | HK1052712B (pt) |
| HR (1) | HRP20020703B1 (pt) |
| HU (1) | HU228067B1 (pt) |
| IL (2) | IL151458A0 (pt) |
| ME (1) | MEP59108A (pt) |
| MX (1) | MXPA02007845A (pt) |
| NO (1) | NO329082B1 (pt) |
| NZ (1) | NZ521036A (pt) |
| PL (1) | PL206818B1 (pt) |
| RU (1) | RU2261254C2 (pt) |
| SI (1) | SI1261625T1 (pt) |
| SK (1) | SK287310B6 (pt) |
| WO (1) | WO2001064715A2 (pt) |
| ZA (1) | ZA200206841B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1308613B1 (it) * | 1999-02-17 | 2002-01-09 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella prevenzione di eventi cardiovascolari. |
| EP1130027A1 (de) * | 2000-02-29 | 2001-09-05 | Aventis Pharma Deutschland GmbH | Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben |
| DE10050091A1 (de) * | 2000-10-09 | 2002-04-25 | Biotechnolog Forschung Gmbh | Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen |
| ITMI20010129A1 (it) * | 2001-01-25 | 2002-07-25 | Pharmacia & Upjohn Spa | Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco |
| DE10258650A1 (de) * | 2002-12-13 | 2004-06-24 | Aventis Pharma Deutschland Gmbh | Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben |
| US7160917B2 (en) * | 2002-12-13 | 2007-01-09 | Sanofi-Aventis Deutschland Gmbh | Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof |
| DE102012016127A1 (de) | 2011-08-31 | 2013-02-28 | Daniel Elias | Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels |
| US11030144B2 (en) * | 2018-12-14 | 2021-06-08 | Texas Instruments Incorporated | Peripheral component interconnect (PCI) backplane connectivity system on chip (SoC) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3442815B2 (ja) * | 1992-05-13 | 2003-09-02 | 第一製薬株式会社 | ジアザビシクロアルケン誘導体 |
| EP0711157A4 (en) * | 1993-08-06 | 1996-07-31 | Smithkline Beecham Corp | ENDOTHELIN RECEPTOR ANTAGONISTS |
| JPH07330622A (ja) * | 1994-06-06 | 1995-12-19 | Asahi Chem Ind Co Ltd | 新規生理活性物質スタキボシンｄ及びその製法 |
| RU2083585C1 (ru) * | 1994-12-13 | 1997-07-10 | Волгоградское акционерное общество открытого типа "Химпром" | Способ получения метилового эфира n-бензилоксикарбонил-l-аспартил-l-фенилаланина |
| JPH08283118A (ja) * | 1995-04-07 | 1996-10-29 | Kao Corp | 美白剤 |
| JPH10251262A (ja) * | 1997-01-13 | 1998-09-22 | Mercian Corp | プロテアーゼ阻害物質およびその製造方法 |
| DE19731571A1 (de) * | 1997-07-23 | 1999-01-28 | Merck Patent Gmbh | Endothelin-Rezeptor-Antagonisten |
| DE19754082A1 (de) * | 1997-12-05 | 1999-06-10 | Knoll Ag | Methode zur Bekämpfung der Fettleibigkeit |
| NZ505295A (en) * | 1997-12-16 | 2002-12-20 | Genencor Int | A method of identifying cellulase gene sequences using conserved amino acid sequence fragments from known cellulase enzymes to provide primer nucleotide sequences |
| EP1130027A1 (de) * | 2000-02-29 | 2001-09-05 | Aventis Pharma Deutschland GmbH | Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben |
-
2000
- 2000-02-29 EP EP00104114A patent/EP1130027A1/de not_active Withdrawn
-
2001
- 2001-02-15 NZ NZ521036A patent/NZ521036A/en not_active IP Right Cessation
- 2001-02-15 ME MEP-591/08A patent/MEP59108A/xx unknown
- 2001-02-15 HR HR20020703A patent/HRP20020703B1/xx not_active IP Right Cessation
- 2001-02-15 JP JP2001564208A patent/JP4787449B2/ja not_active Expired - Fee Related
- 2001-02-15 DE DE60116063T patent/DE60116063T2/de not_active Expired - Lifetime
- 2001-02-15 CN CNB018057144A patent/CN1274715C/zh not_active Expired - Fee Related
- 2001-02-15 PL PL358300A patent/PL206818B1/pl unknown
- 2001-02-15 IL IL15145801A patent/IL151458A0/xx active IP Right Grant
- 2001-02-15 HU HU0204584A patent/HU228067B1/hu not_active IP Right Cessation
- 2001-02-15 AU AU2001250318A patent/AU2001250318B2/en not_active Ceased
- 2001-02-15 CZ CZ20022904A patent/CZ303552B6/cs not_active IP Right Cessation
- 2001-02-15 HK HK03104943.7A patent/HK1052712B/zh not_active IP Right Cessation
- 2001-02-15 AT AT01923574T patent/ATE313556T1/de active
- 2001-02-15 CA CA2401032A patent/CA2401032C/en not_active Expired - Fee Related
- 2001-02-15 ES ES01923574T patent/ES2254394T3/es not_active Expired - Lifetime
- 2001-02-15 SI SI200130491T patent/SI1261625T1/sl unknown
- 2001-02-15 SK SK1226-2002A patent/SK287310B6/sk not_active IP Right Cessation
- 2001-02-15 EP EP01923574A patent/EP1261625B1/en not_active Expired - Lifetime
- 2001-02-15 RU RU2002125877/04A patent/RU2261254C2/ru not_active IP Right Cessation
- 2001-02-15 KR KR1020027011092A patent/KR100997073B1/ko not_active Expired - Fee Related
- 2001-02-15 BR BR0108757-6A patent/BR0108757A/pt active Search and Examination
- 2001-02-15 MX MXPA02007845A patent/MXPA02007845A/es active IP Right Grant
- 2001-02-15 DK DK01923574T patent/DK1261625T3/da active
- 2001-02-15 AU AU5031801A patent/AU5031801A/xx active Pending
- 2001-02-15 EE EEP200200480A patent/EE05406B1/xx not_active IP Right Cessation
- 2001-02-15 WO PCT/EP2001/001661 patent/WO2001064715A2/en not_active Ceased
- 2001-02-27 AR ARP010100884A patent/AR029808A1/es active IP Right Grant
- 2001-02-28 US US09/794,346 patent/US6627604B2/en not_active Expired - Lifetime
-
2002
- 2002-08-25 IL IL151458A patent/IL151458A/en not_active IP Right Cessation
- 2002-08-27 ZA ZA200206841A patent/ZA200206841B/en unknown
- 2002-08-28 NO NO20024105A patent/NO329082B1/no not_active IP Right Cessation
-
2006
- 2006-02-13 CY CY20061100199T patent/CY1105550T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5242000A (en) | Nematicidal trifluorobutenes | |
| BR0107241A (pt) | Compostos, processo de preparação dos compostos, uso dos compostos, composições fungicidas, processo de combate preventivo ou curativo dos fungos fitopatogênicos das culturas e método de tratamento preventivo ou curativo da madeira de construção | |
| BR0215312A (pt) | Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto | |
| BR9813373A (pt) | Composto, processo para a preparação do mesmo, composição farmacêutica, processo para a preparação da mesma, uso de um composto, e, processos para efetuar imunossupressão e para tratar ou reduzir o risco de uma doença das vias aérias obstrutiva reversìvel em um paciente | |
| BR9911482A (pt) | Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto | |
| BR0213139A (pt) | Composto, método de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto e composição farmacêutica | |
| BR0014804A (pt) | Composto, formulação farmacêutica, uso de um composto, método de profilaxia ou tratamento de uma arritmia, e, processo para a preparação de um composto | |
| BR0214142A (pt) | Derivados e intermediários de n-adamantilmetila como composições farmacêuticas e processos para sua preparação | |
| BR0114576A (pt) | Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto | |
| BR9907270A (pt) | Composto, composição farmacêutica, uso de um composto, e, processos para tratamento ou profilaxia de doenças inflamatórias, por exemplo, asma ou copd, e para a preparação de um composto | |
| MY157878A (en) | Stabilized pharmaceutical preparations of gabapentin and process for preparing the same | |
| YU56995A (sh) | Soli derivata indola | |
| BR9812381A (pt) | Peptopiranosilnucleosìdeo, seu preparo e uso | |
| BR0212787A (pt) | Composto ou sal farmaceuticamente aceitável do mesmo, métodos de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto ou sal, e, composição farmacêutica | |
| BR0206935A (pt) | Composto, formulação farmacêutica, uso de um composto, método de tratamento e/ou profilaxia de condições associadas com a inibição da glicogênio sintase quinase-3, e, processo para a preparação de um composto | |
| PL364598A1 (en) | Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments | |
| BR0215395A (pt) | Compostos; processo para a preparação de um composto; composição farmacêutica; e método para o tratamento e/ou profilaxia de doenças que estão relacionadas com o nìvel de glicose no sangue | |
| MY114944A (en) | Propanolamine derivatives, processes for their preparation pharmaceuticals comprising these compounds, and their use | |
| BR0108757A (pt) | Peptìdeos memno processo para a preparação dos mesmos e uso dos mesmos | |
| PT865498E (pt) | Processo para a preparacao de ciclodepsipeptideos com 24 atomos no anel substituidos contendo acido aril-lactico | |
| BR0016678A (pt) | Composto, formulação farmacêutica, uso de um composto, método para profilaxia ou tratamento de uma arritmia, e, processo para preparação de um composto | |
| EP0775746A3 (en) | Coccidiosis poultry vaccine | |
| AU6826700A (en) | Ceramide analogs, process for their preparation and their use as antitumor agents | |
| AU1829195A (en) | Energy formulation | |
| BR9610175A (pt) | Composto processo de preparação do composto composição farmacêutica e utilização do composto |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) Free format text: ALTERADO DE: AVENTIS PHARMA DEUTSCHLAND GMBH |
|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B11D | Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time |